Abstract
The burden of prostate cancer is increasing. Therefore, we need to implement a contemporary, organized, risk-stratified program for early detection to reduce both the harm from the disease and potential overdiagnosis and overtreatment, while avoiding underdiagnosis to considerably improve the harm-to-benefit ratio.
Cite
CITATION STYLE
Van Poppel, H., Hogenhout, R., Albers, P., van den Bergh, R. C. N., Barentsz, J. O., & Roobol, M. J. (2021, March 1). Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. European Urology. Elsevier B.V. https://doi.org/10.1016/j.eururo.2020.12.010
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.